Appears on
Articles3
GLP-1 Agonists May Help People With Diabetes and Long COVID
People with type 2 diabetes face increased risk of severe lung conditions. A new study reported that mice treated with GLP-1agonists showed reduced pulmonary fibrosis. Further trials are needed.
0
ASM19h agoASM Joins the Trust Seal to Advance Confidence in Science
ASM joins a coalition of scientific societies to launch the Trust Seal, a community-led initiative bringing together organizations across the research ecosystem to advance trust in science.
0
ASM16d agoNew ASM President and Leadership Begin Their Terms
ASM welcomes a new president, president-elect and member of the Board of Directors, who will begin their leadership terms on July 1, 2026.
0
ASM8d ago